TAmDeM #1 - Target validation and choice of indications

January 17, 2022 | News

The Rare Diseases Foundation, with the participation and support of Sanofi Genzyme, invites you to follow the TAmDeM podcast " Training of Academics on Drug Development " to understand the stages of drug development, from its creation in an academic laboratory to its marketing by a manufacturer.

It will be broadcasted every month on your music listening applications: Apple Podcasts, Spotify, Google Podcasts, Amazon Music, Deezer.

The first episode is online: thehe validation of targets and the choice of indications


Interviewer: Dr. Christine Fetro / Doctor of Pharmacy, in charge of research development and industrial partnerships at the Foundation

Speaker: Dr. Souad Naimi / Global Head of the Center of Excellence for Molecular & Digital Histopathology at Sanofi's R&D Translational Sciences Unit.

Voice-over : Hervé Haubold / Podcast producer, StereoLab

For more information: https://evenements-fondation-maladiesrares.org/event/podcast-tandem/

Lexicon of the episode: https: //evenements-fondation-maladiesrares.org/event/podcast-tandem/#lexique